Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yana Kropotova"'
Publikováno v:
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-10 (2019)
Abstract Background The incidence of obesity and diabetes is increasing rapidly. Optimal management is still elusive. Obesity associated with type 2 diabetes is known to cause adipose tissue inflammation, increase oxidative stress, and cause white fa
Externí odkaz:
https://doaj.org/article/cc2c4ac78d3c47fe8ea8b1886257f612
Autor:
Cleyton C. Domingues, Fiona J. Dore, Alexander Cho, Neeki Ahmadi, Yana Kropotova, Nabanita Kundu, Naji Younes, Vivek Jain, Sabyasachi Sen
Publikováno v:
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-7 (2019)
Abstract Background Obstructive sleep apnea (OSA) is an independent risk factor for cardiovascular diseases (CVD) and vascular health. Peripheral blood-derived CD34+ progenitor cells have been used as biomarker for CVD risk and may play a similar rol
Externí odkaz:
https://doaj.org/article/21525cf5492646e1b273ebd4d064b76c
Autor:
Fiona J. Dore, Cleyton C. Domingues, Neeki Ahmadi, Nabanita Kundu, Yana Kropotova, Sara Houston, Carol Rouphael, Aytan Mammadova, Linda Witkin, Anamil Khiyami, Richard L. Amdur, Sabyasachi Sen
Publikováno v:
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-13 (2018)
Abstract Aims Type 2 diabetes is associated with endothelial dysfunction leading to cardiovascular disease. CD34+ endothelial Progenitor Cells (EPCs) are responsible for endothelial repair and neo-angiogenesis and can be used as a cardiovascular dise
Externí odkaz:
https://doaj.org/article/6b9c71fc3a5945c4a41c250bc4a60d3d
Autor:
Naomi Dempsey, Nitika Dabas, Yana Kropotova, Amanda Rosenthal, Marc E. Lippman, Nanette H. Bishopric
Publikováno v:
Breast Cancer Research and Treatment. 188:21-36
Despite great success as a targeted breast cancer therapy, trastuzumab use may be complicated by heart failure and loss of left ventricular contractile function. This review summarizes the risk factors, imaging, and prevention of cardiotoxicity assoc
Autor:
Vivek Jain, Cleyton C. Domingues, Fiona J. Dore, Sabyasachi Sen, Neeki Ahmadi, Alexander Cho, Naji Younes, Yana Kropotova, Nabanita Kundu
Publikováno v:
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-7 (2019)
Stem Cell Research & Therapy
Stem Cell Research & Therapy
Background Obstructive sleep apnea (OSA) is an independent risk factor for cardiovascular diseases (CVD) and vascular health. Peripheral blood-derived CD34+ progenitor cells have been used as biomarker for CVD risk and may play a similar role in OSA
Autor:
Andrea P. Espejo-Freire, Leticia Campoverde, Yana Kropotova, Kurt Statz-Geary, Philippos Apolinario Costa, Priscila Barreto Coelho, Steven Bialick, Gina Z. D'Amato, Emily Jonczak, Jonathan C. Trent, Aditi Dhir
Publikováno v:
Journal of Clinical Oncology. 40:e23508-e23508
e23508 Background: Bone sarcomas account for about 5% of cancers in adolescents and young adults (AYA). Outcomes in this population are consistently inferior than children. It is poorly understood whether this is related to the tumor biology or the t
Publikováno v:
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-10 (2019)
Stem Cell Research & Therapy
Stem Cell Research & Therapy
Background The incidence of obesity and diabetes is increasing rapidly. Optimal management is still elusive. Obesity associated with type 2 diabetes is known to cause adipose tissue inflammation, increase oxidative stress, and cause white fat hyperpl
Publikováno v:
Diabetes. 68
Background: Mesenchymal stromal cells (MSCs) can home-in to inflamed fat depots to deliver antioxidants locally and help reduce oxidative stress, inflammation and improve NAFLD in high-fat diet (HFD) induced obese (DIO) diabetic mice. Methods: Antiox
Publikováno v:
Diabetes. 67
Background: Mesenchymal stromal cells (MSCs) are multipotent cells that can home-in to the sites of inflammation. Therefore, antioxidant-upregulated MSCs delivered intra-peritoneally can home-in to local inflamed fat pockets which may reduce inflamma
Autor:
Sabyasachi Sen, Carol Rouphael, Anamil M Khiyami, Neeki Ahmadi, Aytan Mammadova, Fiona J. Dore, Sara Houston, Cleyton C. Domingues, Richard Amdur, Yana Kropotova, Nabanita Kundu, Linda Witkin
Publikováno v:
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-13 (2018)
Cardiovascular Diabetology
Cardiovascular Diabetology
Aims Type 2 diabetes is associated with endothelial dysfunction leading to cardiovascular disease. CD34+ endothelial Progenitor Cells (EPCs) are responsible for endothelial repair and neo-angiogenesis and can be used as a cardiovascular disease risk